{
  "main_header": {
    "sid": 493236,
    "name": "Genomic Valley",
    "stock_name": "Genomic Valley",
    "full_name": "Genomic Valley Biotech Ltd",
    "name_url": "stocks-analysis/genomic-valley",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "28.90",
    "chg": -0.49,
    "chgp": "-1.67%",
    "dir": -1,
    "prev_price": "29.39",
    "mcapval": "8.83 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539206,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "",
    "isin": "INE574D01010",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "28 ",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genomic-valley-493236-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Genomic Valley?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-genomic-valley-3623995",
        "imagepath": "",
        "date": "2025-10-15 22:43:37",
        "description": "Answer:\nThe historical performance of Genomic Valley shows significant fluctuations in its financial metrics over the years.\n\nBreakdown:\nGenomic Valley's net sales have varied considerably, peaking at 2.72 Cr in Mar'23 before dropping to 0.84 Cr in Mar'25. The total operating income followed a similar trend, with a high of 2.72 Cr in Mar'23 and a decrease to 0.84 Cr in Mar'25. The company experienced an operating profit (PBDIT) of 0.43 Cr in Mar'25, a recovery from a loss of -0.30 Cr in Mar'22, indicating improved operational efficiency. Profit before tax also showed a positive trend, reaching 0.44 Cr in Mar'25, while profit after tax was 0.36 Cr in the same period, up from a loss of -0.01 Cr in Mar'22. The operating profit margin improved significantly to 51.19% in Mar'25, reflecting better cost management. Total liabilities decreased to 4.33 Cr in Mar'24 from 7.61 Cr in Mar'21, and total assets also decli..."
      },
      {
        "title": "When is the next results date for Genomic Valley?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-genomic-valley-3605127",
        "imagepath": "",
        "date": "2025-10-08 23:16:07",
        "description": "The next results date for Genomic Valley is scheduled for 15 October 2025...."
      }
    ],
    "total": 12,
    "sid": "493236",
    "stock_news_url": "https://www.marketsmojo.com/news/genomic-valley-biotech-493236"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "17-Oct-2025",
      "details": "Please find enclosed herewith un-audiited financial results for the quarter and half year ended on 30th September 2025.",
      "source": "BSE"
    },
    {
      "caption": "Un-Audited Standalone Financial Results For The Quarter And Half Yearly Ended On September 30Th 2025",
      "datetime": "15-Oct-2025",
      "details": "Please find enclosed herewith unaudited standalone financial results for the Quarter and half Yearly ended on September 30th 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of Sebi (LODR)Regulation 2015 Held On Today I.E. 15Th October 2025",
      "datetime": "15-Oct-2025",
      "details": "Please find enclosed herewith Outcome of Board Meeting Pursuant to regulation 30 of Sebi (LODR)Regulation 2015 held on today i.e. 15th October 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Genomic Valley?

2025-10-15 22:43:37

Answer: The historical performance of Genomic Valley shows significant fluctuations in its financial metrics over the years. Breakdown: Genomic Valley's net sales have varied considerably, peaking at 2.72 Cr in Mar'23 before dropping to 0.84 Cr in Mar'25. The total operating income followed a similar trend, with a high of 2.72 Cr in Mar'23 and a decrease to 0.84 Cr in Mar'25. The company experienced an operating profit (PBDIT) of 0.43 Cr in Mar'25, a recovery from a loss of -0.30 Cr in Mar'22, indicating improved operational efficiency. Profit before tax also showed a positive trend, reaching 0.44 Cr in Mar'25, while profit after tax was 0.36 Cr in the same period, up from a loss of -0.01 Cr in Mar'22. The operating profit margin improved significantly to 51.19% in Mar'25, reflecting better cost management. Total liabilities decreased to 4.33 Cr in Mar'24 from 7.61 Cr in Mar'21, and total assets also decli...

Read More

When is the next results date for Genomic Valley?

2025-10-08 23:16:07

The next results date for Genomic Valley is scheduled for 15 October 2025....

Read More

View All News